Clinical studies recruiting near Lille

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
Phase 1/Phase 2 · CHU de Lille - Hôpital Claude Huriez - Service des Maladies · The Lymphoma Academic Research Organisation · NCT07018752 Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving
NA · University Hospital · University Hospital, Lille · NCT07314229 A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Phase 3 · CHRU Lille · Janssen Research & Development, LLC · NCT06449651 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Centre Oscar Lambret · Eli Lilly and Company · NCT07218380 Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Phase 3 · CHRU Lille · Fondation Hôpital Saint-Joseph · NCT05674994 Clinical Trial Evaluating Secondary HPV Vaccination After Treatment of High-grade Cervical Lesions
Phase 2 · Centre Oscar Lambret · Centre Oscar Lambret · NCT06658405 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · CHRU de Lille · Princess Maxima Center for Pediatric Oncology · NCT05327894 Assessment of Cancer-related Post-traumatic Stress in Patients and Caregivers in the Year Following Diagnosis, and Ident
Phase N/A · Centre Oscar Lambret · Lille University · NCT06944262 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · CHRU de Lille - Hopital Claude Huriez · Miltenyi Biomedicine GmbH · NCT04844866 A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Phase 3 · CHU Lille · Vertex Pharmaceuticals Incorporated · NCT04786262 Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions
NA · Insitut Coeur-Poumon, CHU · University Hospital, Lille · NCT04434586 Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
Phase 1 · CHRU Lille · Ichnos Sciences SA · NCT05862012 Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
Phase 2 · Centre Oscar Lambret · Centre Oscar Lambret · NCT05500391 A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Gr
Phase 2 · Centre Oscar Lambret /ID# 272183 · AbbVie · NCT06682988 A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · Hopital Saint Vincent de Paul - GHICL Lille · Alfasigma S.p.A. · NCT06865417 Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes
NA · Institut Coeur-Poumon, CHU · University Hospital, Lille · NCT03728049 Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
Phase 1/Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06704269 Natural History of Hypereosinophilia and Hypereosinophilic Syndromes
Phase N/A · Hôpital Roger Salengro, CHU · University Hospital, Lille · NCT04018118 Metabolic Fluid Responsiveness in Children
Phase N/A · Hôpital Jeanne de Flandre - CHU de Lille · University Hospital, Bordeaux · NCT07255469 Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
NA · Hôpital Roger Salengro · Ad scientiam · NCT05566769 Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units
NA · Lille University Hospital · Poitiers University Hospital · NCT05686850 Circadian Rhythm Deregulation in Patients With CAPS
NA · Hôpital Claude Huriez (CHU de Lille) · Hospices Civils de Lyon · NCT06544018 Identifying Cellular and Molecular Determinants of Efficacy and Resistance in Patients Undergoing CAR-T Therapy
Phase N/A · Hop Claude Huriez Chu Lille · University Hospital, Lille · NCT07609485 Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
Phase 2 · Service des Maladies du sang Hôpital HURIEZ, CHRU de Lille · University Hospital, Clermont-Ferrand · NCT04935684 Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in Hi
Phase 1/Phase 2 · CHU Lille Unité des Maladies Infectieuses et tropicales · Hospices Civils de Lyon · NCT06306014 TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
Phase N/A · Hopital Roger Salengro · NovoCure Ltd. · NCT06924099 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Ag
Phase 1 · Chu De Lille - Hopital Claude Huriez /ID# 270193 · AbbVie · NCT06896916 Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors
Phase 1/Phase 2 · Centre Oscar Lambret · Centre Leon Berard · NCT07243470 Transplantation After Complete Response In Patients With T-cell Lymphoma
NA · Service Oncologie médicale, HOPITAL SAINT VINCENT-DE-PAUL · Hospices Civils de Lyon · NCT05444712

Look up another city

Look up another condition